Pediatrix Medical (MD) 10-K2004 FY Annual report

Filed: 11 Mar 05, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accelerate, accrual, accurately, aCode, Antenatal, apportionment, bore, borrowed, Cerclage, COSO, Denver, deteriorate, disease, disposition, dispute, divestiture, DSO, Enrique, entirety, entitledEpidemiology, factor, firm, Frameworkissued, frequently, gestation, grew, hereto, history, importantly, Infantscommenced, inInternal, internationally, ISSUER, KeyBank, letter, LLC, Loan, Louisiana, met, miscarriage, multi, outlined, Pedaitrix, preexisting, Preterm, Progesterone, promulgated, properly, ratio, recurrent, regular, regularly, Removal, Rupture, sickle, slight, Sosa, sponsored, Sponsoring, subfacility, SunTrust, suspected, swingline, thereunder, Treadway, Triplet, twelve, Twin, unauthorized, uninsured, unissued, UniversityTM, unused, Wachovia

Removed: appeal, approximated, arrangement, Chairman, charged, created, defendant, District, evaluated, excluding, Fleet, initiated, issuing, leading, mark, nonamortization, pertaining, purpose, reached, recently, reexamination, revised, screen, Southern, vi

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

MD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

Certification Pursuant to 18 U.S.C Section 1350

(Adopted by Section 906 of the Sarbanes-Oxley Act of 2002)

In connection with the Annual Report of Pediatrix Medical Group, Inc. on Form 10-K for the year ended December 31, 2004 (the “Report”), each of the undersigned hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that (i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Pediatrix Medical Group, Inc.

A signed original of this written statement required by Section 906 has been provided to Pediatrix Medical Group, Inc. and will be retained by Pediatrix Medical Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


	By:	/s/ Roger J. Medel, M.D.


	Roger J. Medel, M.D.
	Chief Executive Officer


	By:	/s/ Karl B. Wagner


	Karl B. Wagner
	Chief Financial Officer

March 10, 2005